Evotec Says DiaPep Demise Delays Goals, Spotlight Now On Roche Pact
This article was originally published in The Pink Sheet Daily
Executive Summary
With the disappearance of DiaPep277 due to presumed fraud, Evotec is now looking to its partnership with Roche in Alzheimer’s to bring the German biotech’s first drug to market - but the timeframe will be longer.